Meditation-Based Stress Reduction in Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT00071292
- Brief Summary
The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link mindfulness meditation to reduced inflammation in rheumatoid arthritis (RA)?
How does meditation-based stress reduction compare to DMARDs in managing RA symptoms and joint damage progression?
Which biomarkers (e.g., cytokine profiles, stress hormones) predict response to mindfulness interventions in RA patients?
What adverse events were reported in NCT00071292 and how do they compare to standard RA therapies like TNF inhibitors?
Are there synergistic effects of combining meditation with biologic agents (e.g., adalimumab) for RA treatment?
Trial Locations
- Locations (1)
University of Maryland School of Medicine - Kernan Hospital
🇺🇸Baltimore, Maryland, United States
University of Maryland School of Medicine - Kernan Hospital🇺🇸Baltimore, Maryland, United States